|
FluimediX is backed by a knowledgeable board, with extensive experience within both biotech and microfluidic business development:
- Ole Bitsch-Jensen (Chairman), Investment Manager at SEED Capital focused on diagnostic and medical technology investments
Seed Capital Denmark
- Tom Olesen, Co-founder and Research & Business Development Manager of Unisensor A/S
Unisensor
- Rolf Ehrnström, Member of the Senior Management Team, Research & Development at DAKO
DAKO
- Ove Öhman, Founder of Åmic AB, now part of Johnson & Johnson
Åmic aquired by J&J
- Tomas Ussing (CEO), 15 years of experience as Project Manager and Development Engineer (E)
|
|